期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清铜与临床相关性研究现状 被引量：1

原文传递
导出
摘要 血清铜反映了人体铜代谢水平,其浓度减低或升高都具有较为确切的临床意义。对近几年血清铜与临床相关性研究成果进行了简单综述。
作者 牛丽凤 姜严 尹之全
机构地区 辽宁中医药大学职业技术学院 辽宁阜新市妇幼保健所 辽宁阜新市疾病预防控制中心
出处 《微量元素与健康研究》 CAS 2010年第4期64-64,共1页 Studies of Trace Elements and Health
关键词 血清铜 临床 相关性
分类号 Q592.1 [生物学—生物化学]
  • 相关文献

参考文献10

二级参考文献38

  • 1罗永义,张克荣,李崇福,张瑶,何俊生.活性炭富集火焰原子吸收法测定水中多种元素[J].中国公共卫生,1993,9(5):218-219. 被引量：9
  • 2郭淑兰,李家骥,范琴梅.血清锌测定在肝脏疾病中的临床意义[J].上海医学,1989,12(9):535-535. 被引量：2
  • 3张瑶,张克荣,罗永义,李崇福,蒋丽.活性炭对铅镉镍钴离子的吸附机理探讨[J].华西医科大学学报,1995,26(3):322-325. 被引量：16
  • 4Jesus K Yamamoto-Furusho,Joshua R Korzenik.Crohn’s disease:Innate immunodeficiency?[J].World Journal of Gastroenterology,2006,12(42):6751-6755. 被引量：7
  • 5汪尔康.21世纪分析化学的展望[A]..21世纪的分析化学[C].北京:科学出版社,2000.6-12.
  • 6Roberts EA, Schilsky MI. Diagnosis and treatment of Wilson disease: Anupdate [J]. Hepatology, 2008, 47 (6): 2089- 2111.
  • 7Ferenci P, Caca K, Loudianeos G, et al. Diagnosis and phenotypie classification of Wilson disease [J]. Liver Int, 2003, 23 (3): 139-142.
  • 8Roberts EA, Schilsky MI. A practice guideline on Wilson disease [J]. Hepatology, 2003, 37 (6): 1475-1492.
  • 9Bull PC, Thomas GR, Rommerns JM, et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene [J]. Nat Genet, 1993, 5 (4): 327.
  • 10Bewer GJ. Chapter 3: Simple approaches to screening and definitive diagnosis [A] In Brewer GJ, Eds. Wilson disease: A clinician ' s guide to recognition, diagnosis, and management [ M ] Netherlands: Kluwer Academec Publishers, 2001.

共引文献45

同被引文献14

  • 1Roberts EA,Schilsky MI.Apractice guideline on Wilson disease.Hepatology,2003,37:1475-1492.
  • 2Bruha R,Marecek Z,Pospisilova L,et al.Long-term follow-up of Wilson Disease:natural history,treatment,mutations analysis and phenotypic correlation.Liver Int,2011,31:83-91.
  • 3Koizumi M,Fujii J,Suzuki K,et al.A marked increase in free copper levels in the plasma and liver of LEC rats:an animal model for Wilson disease and liver cancer.Free Radic Res,1998,28:441-450.
  • 4Geetha A,Jeyachristy SA,Selvamathy SM,et al.A study on the concentrations of serum zinc,non-ceruloplasmin copper,reactive oxygen and nitrogen species in children with Wilson's disease.Clin Chim Acta,2007,383:165-167.
  • 5Brewer GJ,Askari F,Dick RB,et al.Treatment of Wilson's disease with tetrathiomolybdate:V.control of free copper by tetrathiomolybdate and a comparison with trientine.Transl Res,2009,154:70-77.
  • 6Merle U,Schaefer M,Ferenci P,et al.Clinical presentation,diagnosis and long-term outcome of Wilson disease-a cohort study.Gut,2007,56:115-120.
  • 7Aruon R,Calderon JF,Schilsky M,et al.Wilson disease in children:serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment.J Pediatr Gastroenterol Nutr,2007,44:596-602.
  • 8Dastych M.Serum levels of zinc,copper and selenium in patients with Wilson's disease treated with zinc.Vnitr Lek,1999,45:217-219.
  • 9Weisner B,Hartard C,Dieu C.CSF copper concentration:a new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation.J Neurol Sci,1987,79:229-237.
  • 10Brewer GJ,Askari F,Lorincz MT,et al.Treatment of Wilson disease with ammonium tetrathiomolybdate:Ⅳ.Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.Arch Neurol,2006,63:521-527.

引证文献1

二级引证文献6

微量元素与健康研究
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部